Apple Watch gets FDA clearance for use in arrhythmia detection
The latest iteration of the Apple Watch, dubbed Series 4 gets FDA clearance for use in detection and notification of atrial fibrillation and other arrhythmias. It generates a single-lead ECG without any special band or third-party add-on. Instead, a user touches a finger to electrodes built into the crown and a new electrical heart rate sensor in the back crystal provides the other contact. Alerts are sent when abnormal rhythms are detected or when heart rat
To continue reading this article
Continue reading your article with a eMediNexus account.